These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis. Buchmann A, Karcier Z, Schmid B, Strathmann J, Schwarz M. Mutat Res; 2008 Feb 01; 638(1-2):66-74. PubMed ID: 17928010 [Abstract] [Full Text] [Related]
24. Low frequency of H-ras mutations in hepatocellular adenomas and carcinomas and in hepatoblastomas from B6C3F1 mice exposed to oxazepam in the diet. Devereux TR, White CM, Sills RC, Bucher JR, Maronpot RR, Anderson MW. Carcinogenesis; 1994 May 01; 15(5):1083-7. PubMed ID: 8200073 [Abstract] [Full Text] [Related]
25. Frequency of ras mutations in liver neoplasms from B6C3F1 mice exposed to tetrafluoroethylene for two years. Hong HH, Devereux TR, Roycroft JH, Boorman GA, Sills RC. Toxicol Pathol; 1998 May 01; 26(5):646-50. PubMed ID: 9789951 [Abstract] [Full Text] [Related]
27. Activation of protooncogenes in mouse lung tumors. You M, Wang Y, Lineen A, Stoner GD, You LA, Maronpot RR, Anderson MW. Exp Lung Res; 1991 May 01; 17(2):389-400. PubMed ID: 2050038 [Abstract] [Full Text] [Related]
28. Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors. Maronpot RR, Fox T, Malarkey DE, Goldsworthy TL. Toxicology; 1995 Aug 25; 101(3):125-56. PubMed ID: 7676462 [Abstract] [Full Text] [Related]
29. Dose-related changes in the profile of ras mutations in chemically induced CD-1 mouse liver tumors. Manam S, Shinder GA, Joslyn DJ, Kraynak AR, Hammermeister CL, Leander KR, Ledwith BJ, Prahalada S, van Zwieten MJ, Nichols WW. Carcinogenesis; 1995 May 25; 16(5):1113-9. PubMed ID: 7767973 [Abstract] [Full Text] [Related]
31. Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines. Belinsky SA, Devereux TR, Maronpot RR, Stoner GD, Anderson MW. Cancer Res; 1989 Oct 01; 49(19):5305-11. PubMed ID: 2670201 [Abstract] [Full Text] [Related]
32. Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse. Devereux TR, Anderson MW, Belinsky SA. Carcinogenesis; 1991 Feb 01; 12(2):299-303. PubMed ID: 1995195 [Abstract] [Full Text] [Related]
34. Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen. Meyer K, Lee JS, Dyck PA, Cao WQ, Rao MS, Thorgeirsson SS, Reddy JK. Carcinogenesis; 2003 May 01; 24(5):975-84. PubMed ID: 12771043 [Abstract] [Full Text] [Related]
36. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis. Khan SG, Mohan RR, Katiyar SK, Wood GS, Bickers DR, Mukhtar H, Agarwal R. Mol Carcinog; 1996 Feb 01; 15(2):96-103. PubMed ID: 8599584 [Abstract] [Full Text] [Related]
37. Incidence of mutations at codon 61 of the Ha-ras gene in liver tumors of mice genetically susceptible and resistant to hepatocarcinogenesis. Dragani TA, Manenti G, Colombo BM, Falvella FS, Gariboldi M, Pierotti MA, Della Porta G. Oncogene; 1991 Feb 01; 6(2):333-8. PubMed ID: 2000226 [Abstract] [Full Text] [Related]